Dr. Emese Zsiros, MD

Dr. Zsiros practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Zsiros' NPI, 1598921181, was assigned on August 3, 2008. Dr. Zsiros holds New York license 276011.

Dr. Zsiros' primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Zsiros' primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Zsiros is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center. Dmand AI also links Dr. Zsiros to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zsiros practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Zsiros' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Zsiros is licensed in New York.

CMS data shows 95 Medicare services from Dr. Zsiros across 2 procedure codes in 2024, all of them office visits, for 70 Medicare patients. Medicare paid $8,407 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Zsiros in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zsiros' median patient age at 70, with 100% women.

Dr. Zsiros accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of removal of the uterus by Dr. Zsiros, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 43 papers to Dr. Zsiros, published from 2013 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Immunotherapy and Tumor Microenvironment. Dr. Zsiros has published most often in Gynecol Oncol. Dr. Zsiros' most frequent co-authors are Paul Christian Mayor, MD, Kristen D. Starbuck, MD and Janos L. Tanyi, MD.

Dmand AI links Dr. Zsiros to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Fallopian Tube Diseases, Neoplasm Metastasis and Fallopian Tube Neoplasms. Roswell Park Cancer Institute sponsors the most, 2.

CMS Open Payments shows 35 general payments to Dr. Zsiros from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 59% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,202.